STOCK TITAN
  1. Home
  2. Sec-filings
  3. HCWB
  4. [8-K] HCW Biologics Inc. Reports Material Event

[8-K] HCW Biologics Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock HCWB logo
Hcw Biologics Inc.

NASDAQ:HCWB

HCWB Rankings

#9203 Ranked by Market Cap
N/A Ranked by Dividends

HCWB Latest News

Jun 27, 2025
HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors
Jun 26, 2025
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
Jun 4, 2025
HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech
May 15, 2025
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results
May 13, 2025
HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

HCWB Latest SEC Filings

Jul 1, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Jun 26, 2025
[8-K] HCW Biologics Inc. Reports Material Event
Jun 23, 2025
[8-K] HCW Biologics Inc. Reports Material Event

HCWB Stock Data

11.22M
1.55M
44.41%
7.02%
1.22%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIRAMAR